|
ARWR Arrowhead Pharmaceuticals Inc 879407 |
| Balance Sheet |
|
Current Assets
|
$1,839,751,000.00 |
|
Assets
|
$2,268,265,000.00 |
|
Current Liabilities
|
$295,220,000.00 |
|
Equity
|
$613,977,000.00 |
|
Shares Out
|
140571000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$97,923,000.00 |
|
Investing Cash Flow
|
$-918,024,000.00 |
| Market Analysis |
Market Cap
|
$12,274,659,720.00 |
|
Price
|
$83.27 |
|
BVPS
|
4.37 |
|
PB
|
19.98 |
|
EPS
|
-0.93 |
|
PS
|
40.03 |
|
FCF
|
$93,210,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:16 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:10 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-05 |
0.22 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-0.93 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-1.26 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-25 |
-0.01 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ARWR documents filed with the SEC.
ARWR Filings
Clear
